Source:http://linkedlifedata.com/resource/pubmed/id/10607765
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2000-2-24
|
pubmed:abstractText |
The prognosis of IgA nephropathy (IgAN) is variable and about 10-20% of patients progress to end-stage renal disease (ESRD) in 10 years. Hypertension, proteinuria and renal insufficiency at the time of diagnosis are risk factors associated with poor prognosis. Lipid abnormalities may have a role in the progression of glomerulonephritides, and glomerulosclerosis and atherosclerosis may have similar pathophysiological mechanisms. We therefore evaluated factors associated with cardiovascular diseases, especially hypercholesterolaemia, hypertriglyceridaemia, and hyperuricaemia, as predictors of the progression of IgAN.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0931-0509
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
34-42
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10607765-Adolescent,
pubmed-meshheading:10607765-Adult,
pubmed-meshheading:10607765-Aged,
pubmed-meshheading:10607765-Child,
pubmed-meshheading:10607765-Female,
pubmed-meshheading:10607765-Glomerulonephritis, IGA,
pubmed-meshheading:10607765-Humans,
pubmed-meshheading:10607765-Hypercholesterolemia,
pubmed-meshheading:10607765-Hypertriglyceridemia,
pubmed-meshheading:10607765-Kidney Failure, Chronic,
pubmed-meshheading:10607765-Lipids,
pubmed-meshheading:10607765-Male,
pubmed-meshheading:10607765-Middle Aged,
pubmed-meshheading:10607765-Prognosis,
pubmed-meshheading:10607765-Risk Factors,
pubmed-meshheading:10607765-Uric Acid
|
pubmed:year |
2000
|
pubmed:articleTitle |
Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy.
|
pubmed:affiliation |
Department of Medicine, Tampere University Hospital and Medical School, University of Tampere, Tampere, Finland.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|